Of mice and mechanisms: identifying the role of complement in monoclonal antibody-based immunotherapy.
Taylor
Ronald P
RP
Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia, USA. rpt@virginia.edu
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003165:Complement System Proteins / Q000502:physiology*; D004195:Disease Models, Animal; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D051379:Mice; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D003165:Complement System Proteins